US drug regulator clears Johnson & Johnson’s vaccine
The US drug regulator (FDA) approved Johnson & Johnson’s single-dose vaccine against coronavirus for emergency use, making it the third shot for the country as it races against time to vaccinate as many people as possible. In clinical trials across the world, J&J's vaccine showed showed 85 per cent efficacy against severe forms of Covid-19 and 100 per cent efficacy against hospitalisation and death. The company said it would provide the United States with 100 million doses by the end of June. Read here
Let's look at the global statistics
Global infections: